Study finds numerous drug combinations sold in India lack regulatory approval

Almost two-thirds of the drug combinations widely sold in India to fight pain, depression, and psychotic conditions lack the necessary regulatory approvals, despite some of the pills being banned internationally, a study has shown.

http://in.reuters.com/article/2015/05/12/us-india-fdc-regulations-idINKBN0NX29720150512

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING